A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Clinical trial NCT06866574 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06866574
Sponsor: Xiamen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Penile/Perineal /Perianal Intraepithelial Neoplasia Anal Intraepithelial Neoplasia Penile/Perianal/Perineal Cancer Anal Cancer Genital Warts

Start date: 2025-04-11
Primary completion: 2031-09-30
Enrollment: 9300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.